Mon.Aug 01, 2022

Concert to seek approval for hair loss drug after second study success

Bio Pharma Dive

The biotech plans to file an application with the FDA in the first half of next year for clearance in alopecia areata, potentially positioning it to compete with Eli Lilly and Pfizer for market share

Healthcare stories in the news

World of DTC Marketing

Democrats have been campaigning for 30 years on promises they’d let Medicare directly negotiate the cost of prescription drugs. Now, after the majority of voters want reduced costs for their prescription drugs, the bill seems ready to pass despite record pharma lobbying.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The promise of oral therapies for cytokine inhibition

Bio Pharma Dive

The science behind new oral therapies for cytokine inhibition and why they could be transformational for patients


Moderna signs contract to supply Covid-19 booster vaccines to the US

Pharmaceutical Technology

Moderna has entered a new supply contract with the US Government to deliver 66 million doses of its Covid-19 vaccine booster candidate, mRNA-1273.222.

RNA 94

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

The cost of purpose: Finding personal fulfillment in a pharmaceutical career

Bio Pharma Dive

Wa’el Hashad, President and CEO of Avanir Pharmaceuticals, discusses purpose and fulfillment in a pharmaceutical career


AbbVie reports 4.5% rise in Q2 2022 net revenues

Pharmaceutical Technology

AbbVie has reported net revenues of $14.6bn for the second quarter (Q2) of 2022 as against $14bn in the year-ago quarter, indicating a 4.5% rise on a GAAP basis. Net revenue surged by 6.1% on an operational basis during the quarter.

Sales 83

More Trending

GreenLight and US NIH partner to develop Covid-19 vaccine for variants

Pharmaceutical Technology

GreenLight Biosciences has entered a partnership with the US National Institutes of Health (NIH) for the development of Covid-19 vaccines, which offer broader protection against new variants and with durable effects.

RNA 82

FDA halts testing of Beam’s base editing cancer therapy

Bio Pharma Dive

The regulator has put on hold human testing of a blood cancer treatment known as BEAM-201, one of two that the biotech aims to bring to clinical trials this year

Governments and pharma relationships and implications for antimicrobial resistance

Pharmaceutical Technology

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. The pandemic forced governments to acknowledge that this status quo had to change.

Nuvation to cut workforce by 35% as it scraps lead drug program

Bio Pharma Dive

The company, which is led by former Medivation executives and focuses on cancer research, said the shake-up is in response to an “internal risk-benefit analysis” that raised doubts about its most advanced program

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Pfizer, Moderna deals for revamped COVID shots won’t be enough without more funding, HHS says

Fierce Pharma

Pfizer, Moderna deals for revamped COVID shots won’t be enough without more funding, HHS says. fkansteiner. Mon, 08/01/2022 - 08:17


Ipsen, continuing oncology push, pays a startup $45M for two cancer drugs

Bio Pharma Dive

The French company will work with Marengo Therapeutics in an alliance that could be worth as much as $1.6 billion

Drugs 164

Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts

Fierce Pharma

Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts. esagonowsky. Mon, 08/01/2022 - 09:25


Sarepta says early filing for DMD gene therapy is back on


Sarepta is pressing forward with a bold plan to file with the FDA for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy (DMD) in the next few months, with a view to making it available in sometime around the middle of 2023.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Gilead pads case for top-seller Biktarvy in HIV, hepatitis B co-infection

Fierce Pharma

Gilead pads case for top-seller Biktarvy in HIV, hepatitis B co-infection. fkansteiner. Mon, 08/01/2022 - 09:28


Top Five Fastest Growing Beverage Companies in 2022


Whether it’s coffee, tea, soda, beer or water, consumers have been finding ways to quench their thirst for centuries, making the beverage industry both timeless and recession-proof.

Sales 87

Johnson & Johnson isn't finished with Emergent dispute, files arbitration demand

Fierce Pharma

Johnson & Johnson isn't finished with Emergent dispute, files arbitration demand. zbecker. Mon, 08/01/2022 - 11:01


BMS’ plan to move Opdivo into adjuvant RCC gets knocked back


Bristol-Myers Squibb has revealed that its checkpoint inhibitor combination of Opdivo and Yervoy failed a phase 3 trial as adjuvant (post-surgery) therapy for renal cell carcinoma (RCC), the most common form of kidney cancer.

GCP update: advice on what to expect and how to prepare

Outsourcing Pharma

With updates to the Guideline for Good Clinical Practice Advancements on the horizon, an industry expert offers some perspective on what might be ahead. Markets & Regulations

GSK ups sales guidance on back of Shingrix strength

BioPharma Reporter

GSKâs first quarter following the demerger of its consumer health business sees the company raise its 2022 sales guidance to between 6-8%, up from 5-7% on its previous estimation. Markets & Regulations

Sales 83

Curavit, Swing team up on fibromyalgia therapeutic trial

Outsourcing Pharma

The CRO and DTx specialist are joining forces to conduct a hybrid clinical trial of a potential digital therapeutic that is aimed at treating fibromyalgia. Clinical Development

STELARA® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis

The Pharma Data

As the first and only biologic targeting both cytokines interleukin (IL)-12 and IL-23, STELARA provides a new therapeutic option for children six years of age and older living with active psoriatic arthritis.

Data analytics hiring levels in the pharmaceutical industry dropped in July 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for data analytics related positions dropped in July 2022 compared with the equivalent month last year, with 64.8% of the companies included in our analysis recruiting for at least one such position. This latest figure was lower than the 68.8%


Bayer expands existing investment to acquire majority share in sustainable lower carbon oilseed producer CoverCress Inc.

The Pharma Data

The Win-Win with Virtual Visits – Better Experiences, Better Data

Crucial Data Soutions

Today, many factors are coming together to push the clinical research industry beyond the exclusive reliance on traditional clinical trial sites.

New global alliance launched to end AIDS in children by 2030

The Pharma Data

Globally, only half (52%) of children living with HIV are on life-saving treatment. UNAIDS, UNICEF, and WHO have brought together a new alliance to fix one of the most glaring disparities in the AIDS response.

US Government Purchases 66 Million Doses of Moderna’s COVID-19 Booster Candidate

Pharmaceutical Commerce

Price tag for bivalent dose was $1.74 billion.


GSK signs agreement to support pandemic preparedness in Europe

The Pharma Data

Being Honest About Your Medical History

Riverside Clinical Research

You might be surprised at how often people lie about their medical information or omit vital information about their medical history, but in the case of a clinical trial, providing accurate details and as much information as possible as it relates to medical information and history is absolutely imperative.

Cyclerion reveals data for schizophrenia therapy


Study data demonstrates positive effects of CY6463 on cognition and inflammation


Philips on designing innovation and cultivating partnerships – part two


This article follows part one of our two-part series, where we discussed how Philips designs innovation and digital health solutions for areas of India’s healthcare system where options are sparse. .

Ipsen and Marengo Therapeutics announce strategic partnership


Deal will advance precision immuno-oncology candidates from Marengo’s STAR platform


Pfizer and BioNTech start trial of ‘next-gen’ COVID vaccine

BioPharma Reporter

The two companies have begun a Phase II study on an âenhancedâ version of their mRNA vaccine against COVID-19. Bio Developments

Novasep-PharmaZell commits nearly$7.5m to boosting API capacity

Outsourcing Pharma

The contract development and manufacturing organization plans to invest â7.3m to expand and upgrade API production capacity at its Mourenx, France facility. Ingredients